STAT December 15, 2023
Joseph P. Allen

The Bayh-Dole Act is widely credited with kickstarting a new era of American innovation involving the launch of 17,000 startup companies and some 495,000 inventions.

Yet despite this success, Bayh-Dole now finds itself vulnerable — and from a surprising source.

Back in 1980, a young senator from Delaware named Joe Biden was among those who supported Bayh-Dole in the Senate Judiciary Committee. His “yes” contributed to the bill’s 91-4 approval in the Senate. Later in his Senate career, Biden voted against then-Rep. Bernie Sanders’ attempt to amend the law so the government could second-guess the pricing of successfully commercialized inventions. As president, his administration issued one of the strongest denials of attempts to misuse the law for the same purpose.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article